GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+20.29%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$374M
AUM Growth
+$374M
(+29%)
Cap. Flow
+$47.3M
Cap. Flow
% of AUM
12.64%
Top 10 Holdings %
Top 10 Hldgs %
44.45%
Holding
75
New
29
Increased
7
Reduced
10
Closed
22
Top Buys
| 1 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$20M |
| 2 |
Sarepta Therapeutics
SRPT
|
$17.4M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$16.9M |
| 4 |
Gyre Therapeutics
GYRE
|
$11.6M |
| 5 |
Amicus Therapeutics
FOLD
|
$11.3M |
Top Sells
Sector Composition
| 1 | Healthcare | 83.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $27M | 5.47% | 1,850,000 +312,000 | +20% | +$4.56M |
|
|
ECYT
2
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $20M | 4.05% | +2,200,000 | New | +$20M |
|
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $17.4M | 3.52% | +235,000 | New | +$17.4M |
|
|
4
Iovance Biotherapeutics
IOVA
$807M
| $16.9M | 3.42% | +1,000,000 | New | +$16.9M |
|
|
AVXS
5
DELISTED
AveXis, Inc. Common Stock
AVXS
| $16.7M | 3.38% | 135,000 +50,000 | +59% | +$6.18M |
|
6
Rocket Pharmaceuticals
RCKT
$354M
| $15.9M | 3.22% | 850,000 -450,000 | -35% | -$8.44M |
|
7
Viatris
VTRS
$12.3B
| $14.4M | 2.92% | 350,000 +100,000 | +40% | +$4.12M |
|
|
BHVN
8
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $14.2M | 2.87% | 550,000 +365,000 | +197% | +$9.4M |
|
9
argenx
ARGX
$43.6B
| $12.1M | 2.44% | 150,000 -100,000 | -40% | -$8.04M |
|
|
10
Gyre Therapeutics
GYRE
$703M
| $11.6M | 2.35% | +450,000 | New | +$11.6M |
|
|
11
Amicus Therapeutics
FOLD
$2.34B
| $11.3M | 2.28% | +750,000 | New | +$11.3M |
|
|
BPMC
12
DELISTED
Blueprint Medicines
BPMC
| $11M | 2.23% | 120,000 -30,000 | -20% | -$2.75M |
|
13
Ascendis Pharma
ASND
$11.8B
| $9.16M | 1.85% | 140,000 -110,000 | -44% | -$7.19M |
|
|
DRNA
14
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $9.08M | 1.84% | 950,000 +450,000 | +90% | +$4.3M |
|
|
MNTA
15
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $9.08M | 1.84% | +500,000 | New | +$9.08M |
|
16
Acadia Pharmaceuticals
ACAD
$4.38B
| $8.99M | 1.82% | +400,000 | New | +$8.99M |
|
|
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.06M | 1.63% | 262,500 -337,500 | -56% | -$10.4M |
|
|
CNCE
18
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $8.02M | 1.62% | +350,000 | New | +$8.02M |
|
|
ADMS
19
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $7.77M | 1.57% | +325,000 | New | +$7.77M |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $7.57M | 1.53% | 45,000 -750 | -2% | -$126K |
|
21
Assembly Biosciences
ASMB
$190M
| $7.37M | 1.49% | +150,000 | New | +$7.37M |
|
22
Travere Therapeutics
TVTX
$1.56B
| $7.03M | 1.42% | +314,367 | New | +$7.03M |
|
|
KDMN
23
DELISTED
Kadmon Holdings, Inc.
KDMN
| $6.8M | 1.38% | 1,600,000 +900,000 | +129% | +$3.83M |
|
|
AVDL
24
Avadel Pharmaceuticals
AVDL
$1.43B
| $6.2M | 1.25% | +850,000 | New | +$6.2M |
|
|
VRAY
25
DELISTED
ViewRay, Inc.
VRAY
| $5.79M | 1.17% | 900,000 | – | – |
|